ArticleCell death & disease2026

CFTR-driven immune microenvironment reprogramming synergizes with anti-PD-L1 antibody in hepatocellular carcinoma.

Yijia Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.